15 April 2021>: Clinical Research
Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study
Shujie Huang 12ABCDE* , Weitao Zhuang 12ABDEF* , Dongya Wang 34BDF , Lulu Zha 34BD , Xi Xu 34BCD , Xiangdong Li 34BF , Qiuling Shi 5CDE , Xin Shelley Wang 6CDE , Guibin Qiao 17A*DOI: 10.12659/MSM.930447
Med Sci Monit 2021; 27:e930447
Table 1 Clinicopathological characteristics of COVID-19 patients.
Clinicopathological characteristics | n (%) |
---|---|
Male | 44 (59.46) |
Female | 30 (40.54) |
52.3±13.3 | |
Shortness of breath | 27 (36.5) |
Muscle pain | 15 (20.3) |
Fever | 54 (73.0) |
Chills | 6 (8.1) |
Fatigue | 22 (29.7) |
Headache | 3 (4.1) |
Dry mouth | 1 (1.35) |
Sore throat | 1 (1.35) |
Dyspnea | 5 (6.8) |
Cough (sputum production) | 32 (43.2) |
Dry cough | 18 (24.3) |
Palpitation | 3 (4.1) |
Chest tightness | 10 (13.5) |
Chest pain | 3 (4.1) |
Nausea | 2 (2.7) |
Diarrhea | 5 (6.8) |
23.7±13.7 | |
Moderate cases | 60 (81.08) |
Severe cases | 14 (18.92) |
Hypertension | 21 (28.38) |
Aneurysm | 1 (1.35) |
Hyperlipidemia | 2 (2.70) |
Coronary atherosclerotic heart disease | 3 (4.05) |
Cardiac insufficiency | 1 (1.35) |
Bradycardia | 1 (1.35) |
DVT | 1 (1.35) |
Hypothyroidism | 2 (2.70) |
Diabetes mellitus type II | 11 (14.86) |
Bulla | 3 (4.05) |
COPD | 2 (2.70) |
Lung cancer | 1 (1.35) |
Hyperuricemia | 1 (1.35) |
Gouty arthritis | 1 (1.35) |
Chronic gastritis | 1 (1.35) |
Fatty liver | 2 (2.70) |
Hepatitis B | 3 (4.05) |
Gallstone | 1 (1.35) |
Kidney cyst | 1 (1.35) |
Chronic Kidney disease | 1 (1.35) |
Kidney cancer | 1 (1.35) |
Breast cancer | 1 (1.35) |
21 (12.0–34.3) | |
No | 13 (17.57) |
Yes | 61 (82.43) |
No | 71 (95.95) |
Yes | 3 (4.05) |
No | 68 (91.89) |
Yes | 6 (8.11) |
No | 32 (43.24) |
Yes | 42 (56.76) |
No | 43 (58.11) |
Yes | 31 (41.89) |
No | 61 (82.43) |
Yes | 13 (17.57) |
No | 46 (62.2) |
Yes | 28 (37.8) |
WBC (×10/L) | 6.14±1.94 |
RBC (×10/L) | 4.14±0.59 |
Hemoglobin (g/L) | 128.36±16.92 |
Platelet (×10/L) | 244.14±78.69 |
Neutrophil (×10/L) | 3.98±1.80 |
Lymphocyte (×10/L) | 1.55±0.57 |
Monocyte (×10/L) | 0.46±0.17 |
Eosinophil (×10/L) | 0.12±0.11 |
Basophil (×10/L) | 0.02±0.01 |
C-reactive protein (mg/L) | 14.65±33.03 |
hs-C-reactive protein (mg/L) | 3.00±2.49 |
PCT (ng/ml) | 0.07±0.09 |
SARS-CoV-IgM antibody | 76.46±97.14 |
SARS-CoV-IgG-antibody | 143.97±46.11 |